Predicting factors of adverse pregnancy outcomes in Thai patients with systemic lupus erythematosus: A STROBE-compliant study.

Medicine
Worawit LouthrenooAntika Wongthanee

Abstract

Studies on predicting factors for adverse pregnancy outcomes (APOs) in Thai patients with systemic lupus erythematosus (SLE) are limited. This retrospective observation study determined APOs and their predictors in Thai patients with SLE.Medical records of pregnant SLE patients in a lupus cohort, seen from January 1993 to June 2017, were reviewed.Ninety pregnancies (1 twin pregnancy) from 77 patients were identified. The mean age at conception was 26.94 ± 4.80 years. At conception, 33 patients (36.67%) had active disease, 23 (25.56%) hypertension, 20 (22.22%) renal involvement, and 6 of 43 (13.95%) positive anti-cardiolipin antibodies or lupus anti-coagulants, and 37 (41.11%) received hydroxychloroquine. Nineteen patients (21.11%) had pregnancy loss. Of 71 successful pregnancies, 28 (31.11%) infants were full-term, 42 (46.67%) pre-term and 1 (11.11%) post-term; 19 (26.39%) were small for gestational age (SGA), and 38 (52.58%) had low birth weight (LBW). Maternal complications occurred in 21 (23.33%) pregnancies [10 (11.11%) premature rupture of membrane (PROM), 8 (8.89%) pregnancy induced hypertension (PIH), 4 (4.44%) oligohydramnios, 2 (2.22%) post-partum hemorrhage, and 1 (1.11%) eclampsia]. Patients aged ≥ 25 years at pregna...Continue Reading

References

Jul 1, 1996·Annals of the Rheumatic Diseases·N M BuchananG R Hughes
Jun 23, 2005·American Journal of Obstetrics and Gynecology·Eliza F ChakravartyMaurice L Druzin
Nov 1, 2006·Arthritis and Rheumatism·Megan E B ClowseMichelle Petri
Mar 17, 2010·The Journal of Rheumatology·D D GladmanM B Urowitz
Apr 21, 2011·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Jun-tao LiuFengchun Zhang
Jun 3, 2011·The Journal of Rheumatology·Kate BramhamCatherine Nelson-Piercy
Oct 25, 2011·International Journal of Medical Sciences·Hyun Sun KoJong Chul Shin
Jun 29, 2013·Archives of Gynecology and Obstetrics·Riza MadazliHandan Yilmaz
Nov 16, 2014·Immunologic Research·Elisabetta BorellaAndrea Doria
Jun 23, 2015·Annals of Internal Medicine·Jill P BuyonJane E Salmon
Jul 6, 2016·Journal of Autoimmunity·Gabriella MoroniMarta Mosca
Jul 28, 2016·Advances in Pharmacology·J S Possomato-Vieira, Raouf A Khalil
Jul 29, 2016·International Journal of Women's Health·Yuriko Yamamoto, Shigeru Aoki
Sep 16, 2016·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Mohamed RezkHassan Badr
Apr 10, 2017·Rheumatic Diseases Clinics of North America·Aisha Lateef, Michelle Petri
Jul 17, 2017·Seminars in Nephrology·Liz Lightstone, Michelle A Hladunewich
Aug 9, 2020·American Journal of Physiology. Heart and Circulatory Physiology·Hongmei Qu, Raouf A Khalil
Oct 6, 2020·Frontiers in Immunology·Ingrid AnemanLana McClements
Oct 22, 2020·Mediators of Inflammation·Michał MichalczykRafał Rzepka
Nov 21, 2020·Antioxidants·Cha HanJingfei Dong

Methods Mentioned

BETA
cesarean section
SGA
biopsy

Related Concepts

Related Feeds

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.